Chemo-Resistant protein expression pattern of glioblastoma cells (A172) to perillyl alcohol

Journal of Proteome Research

Volumn 10, Issue 1, 2011, Pages 153-160

  Da Gama Fischer, De Saldanha Juliana ^a,b   Carvalho, Paulo Costa ^a,c   Da Fonseca, Clovis Orlando ^d   Liao, Lujian ^e   Degrave, Wim M ^b   Da Costa Carvalho, Maria Da Gloria ^f   Yates, John R ^e   Domont, Gilberto B ^f  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

^b Laboratory for Functional Genomics and Bioinformatics Oswaldo Cruz   (United States)

^c Laboratory of Toxinology Oswaldo Cruz Institute   (Brazil)

^d Fluminence Federal University   (Brazil)

^e SCRIPPS RESEARCH INSTITUTE   (United States)

^f FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

A172 cells; Glioblastoma; MudPIT; Perillyl alcohol; Protein profile; Resistant

Indexed keywords

PERILLYL ALCOHOL; RAS PROTEIN;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER PATIENT; CANCER RESISTANCE; CANCER SIZE; CELL FUNCTION; CLINICAL TRIAL (TOPIC); CONTROLLED STUDY; GLIOBLASTOMA; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; RECURRENT CANCER; TECHNOLOGY; TUMOR GROWTH;

ANTINEOPLASTIC AGENTS; BLOTTING, WESTERN; BRAIN; CELL LINE, TUMOR; CLINICAL TRIALS AS TOPIC; DRUG RESISTANCE, NEOPLASM; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; GLIOBLASTOMA; HUMANS; MAGNETIC RESONANCE IMAGING; MONOTERPENES; PEPTIDE FRAGMENTS; PROTEOME; PROTEOMICS; REPRODUCIBILITY OF RESULTS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

EID: 79951532462     PISSN: 15353893     EISSN: 15353907     Source Type: Journal    
DOI: 10.1021/pr100677g     Document Type: Article

References (50)

1. Da Fonseca, C. O.; Schwartmann, G.; Fischer, J. S. G.; Nagel, J.; Futuro, D.; Quirico-Santos, T.; Gattass, C. R. Preliminary results from a phase I/II study of perillyl alcohol intranasal administration in adults with recurrent malignant gliomas. Surg. Neurol. 2008, 70, 259-67.
2. Clark, S. S.; Zhong, L.; Filiault, D.; Perman, S.; Ren, Z.; Gould, M.; Yang, X. Anti-leukemia effect of perillyl alcohol in Bcr/Abltransformed cells indirectly inhibits signaling through Mek in a Ras- and Raf-independent fashion. Clin. Cancer Res. 2003, 12, 4494-504.
3. Yeruva, L.; Pierre, K. J.; Elegbede, A.; Wang, R. C.; Carper, S. W. Perillyl alcohol and perillic acid induced cell cycle arrest and apoptosis in non small cell lung cancer cells. Cancer Lett. 2007, 2, 216-26. (Pubitemid 47538829)
4. Clark, S. S. Perillyl alcohol induces c-Myc-dependent apoptosis in Bcr/Abl-transformed leukemia cells. Oncology 2006, 1, 13-18.
5. Chung, B. H.; Lee, H. Y.; Lee, J. S.; Young, C. Y. Perillyl alcohol inhibits the expression and function of the androgen receptor in human prostate cancer cells. Cancer Lett. 2006, 2, 222-28.
6. Yuri, T.; Danbara, N.; Tsujita-Kyutoku, M.; Kiyozuka, Y.; Senzaki, H.; Shikata, N.; Kanzaki, H.; Tsubura, A. Perillyl alcohol inhibits human breast cancer cell growth in vitro and in vivo. Breast Cancer Res. Treat. 2004, 3, 251-60. (Pubitemid 38445375)
7. Loutrari, H.; Hatziapostolou, M.; Skouridou, V.; Papadimitriou, E.; Roussos, C.; Kolisis, F. N. Papapetropoulos, A. Perillyl alcohol is an angiogenesis inhibitor. J. Pharmacol. Exp. Ther. 2004, 2, 568-75. (Pubitemid 39391541)
8. Teruszkin, B. I.; Ves, de P. S.; Henriques, S. N.; Curie, C. M.; Gibaldi, D.; Bozza, M.; O, Da Fonseca, C. O.; Carvalho, M. G. C. Effects of perillyl alcohol in glial C6 cell line in vitro and anti-metastatic activity in chorioallantoic membrane model. Int. J. Mol. Med. 2002, 6, 785-8.
9. Meadows, S. M.; Mulkerin, D.; Berlin, J.; Bailey, H.; Kolesar, J.; Warren, D.; Thomas, J. P. Phase II trial of perillyl alcohol in patients with metastatic colorectal cancer. Int. J. Gastrointest. Cancer 2002, 2-3, 125-8. (Pubitemid 36749000)
10. Stearns, V.; Coop, A.; Singh, B.; Gallagher, A.; Yamauchi, H.; Lieberman, R.; Pennanen, M.; Trock, B.; Hayes, D. F.; Ellis, M. J. A pilot surrogate end point biomarker trial of perillyl alcohol in breast neoplasia. Clin. Cancer Res. 2004, 22, 7583-91. (Pubitemid 39557520)
11. Bailey, H. H.; Levy, D.; Harris, L. S.; Schink, J. C.; Foss, F.; Beatty, P.; Wadler, S. A phase II trial of daily perillyl alcohol in patients with advanced ovarian cancer: Eastern Cooperative Oncology Group Study E2E96. Gynecol. Oncol. 2002, 3, 464-8. (Pubitemid 34651886)
12. Fischer, J. G. S.; Carvalho, P. C.; Neves-Ferreira, A. G. C.; Da Fonseca, C. O.; Perales, J.; Carvalho, M. G. C.; Domont, G. B. Antithrombin as prognostic biomarker candidate for patients with recurrent glioblastoma multiform under treatment with perillyl alcohol. J. Exp. Ther. Oncol. 2008, 7, 285-90.
13. Liu, H.; Sadygov, R. G.; Yates, J. R., III. A model for random sampling and estimation of relative protein abundance in shotgun proteomics. Anal. Chem. 2004, 14, 4193-201. (Pubitemid 38943698)
14. Carvalho, P. C.; Hewel, J.; Barbosa, V. C.; Yates, J. R., III. Identifying differences in protein expression levels by spectral counting and feature selection. Genet. Mol. Res. 2008, 2, 342-56.
15. Carvalho, P. C.; Fischer, J. S. G.; Chen, E. I.; Yates, J. R., III; Barbosa, V. C. PatternLab for proteomics: a tool for differential shotgun proteomics. BMC Bioinform. 2008, 9, 316.
16. Fischer, J. S. G.; Liao, L.; Carvalho, P. C.; Barbosa, V. C.; Domont, G. B.; Carvalho, M. G. C.; Yates, J. R., III. Dynamic proteomic overview of glioblastoma cells (A172) exposed to perillyl alcohol. J. Proteomics 2010, 73, 1018-27.
17. Washburn, M. P.; Wolters, D.; Yates, J. R., III. Large-scale analysis of the yeast proteome by multidimensional protein identification technology. Nat. Biotechnol. 2001, 3, 242-7. (Pubitemid 32220565)
18. McDonald, W. H.; Tabb, D. L.; Sadygov, R. G.; MacCoss, M. J.; Venable, J.; Graumann, J.; Johnson, J. R.; Cociorva, D.; Yates, J. R., III. MS1, MS2, and SQT-three unified, compact, and easily parsed file formats for the storage of shotgun proteomic spectra and identifications. Rapid Commun. Mass Spectrom. 2004, 18, 2162-68. (Pubitemid 39222458)
19. Kersey, P. J.; Duarte, J.; Williams, A.; Karavidopoulou, Y.; Birney, E.; Apweiler, R. The International Protein Index: an integrated database for proteomics experiments. Proteomics 2004, 7, 1985-88. (Pubitemid 38880363)
20. Peng, J.; Elias, J. E.; Thoreen, C. C.; Licklider, L. J.; Gygi, S. P. Evaluation of multidimensional chromatography coupled with tandem mass spectrometry (LC/LC-MS/MS) for large-scale protein analysis: the yeast proteome. J. Proteome Res. 2003, 1, 43-50. (Pubitemid 36207189)
21. Tabb, D. L.; McDonald, W. H.; Yates, J. R., III. DTASelect and Contrast: tools for assembling and comparing protein identifications from shotgun proteomics. J. Proteome Res. 2002, 1, 21-6.
22. Eng, J. K. L.; McCormack, A.; Yates, J. R., III. An Approach to Correlate Tandem Mass Spectral Data of Peptides with Amino Acid Sequences in a Protein Database. J. Am. Soc. Mass Spectrom. 1994, 5, 976-89.
23. Benjamini, Y.; Hochberg, Y. Controlling the false discovery rate: a practical and powerful. J. R. Stat. Soc., Ser. B. 1995, 57, 289-300.
24. Carvalho, P. C.; Fischer, J. S. G.; Chen, E. I.; Domont, G. B.; Carvalho, M. G. C.; Degrave, W. M.; Yates, J. R., III; Barbosa, V. C. GO Explorer: A gene-ontology tool to aid in the interpretation of shotgun proteomics data. Proteome Sci. 2009, 7, 6.
25. Hardcastle, I. R.; Rowlands, M. G.; Barber, A. M.; Grimshaw, R. M.; Mohan, M. K.; Nutley, B. P.; Jarman, M. Inhibition of protein prenylation by metabolites of limonene. Biochem. Pharmacol. 1999, 7, 801-9. (Pubitemid 29094551)
26. Crowell, P. L.; Ren, Z.; Lin, S.; Vedejs, E.; Gould, M. N. Structureactivity relationships among monoterpene inhibitors of protein isoprenylation and cell proliferation. Biochem. Pharmacol. 1994, 8, 1405-15. (Pubitemid 24130935)
27. Mills, J. J.; Chari, R. S.; Boyer, I. J.; Gould, M. N.; Jirtle, R. L. Induction of apoptosis in liver tumors by the monoterpene perillyl alcohol. Cancer Res. 1995, 5, 979-83.
28. Fernandes, J.; Da Fonseca, C. O.; Teixeira, A.; Gattass, C. R. Perillyl alcohol induces apoptosis in human glioblastoma multiforme cells. Oncol. Rep. 2005, 5, 943-7.
29. Bardon, S.; Picard, K.; Martel, P. Monoterpenes inhibit cell growth, cell cycle progression, and cyclin D1 gene expression in human breast cancer cell lines. Nutr. Cancer 1998, 1, 1-7. (Pubitemid 28519235)
30. Bardon, S.; Foussard, V.; Fournel, S.; Loubat, A. Monoterpenes inhibit proliferation of human colon cancer cells by modulating cell cycle-related protein expression. Cancer Lett. 2002, 2, 187-94. (Pubitemid 34518303)
31. Rajesh, D.; Howard, S. P. Perillyl alcohol mediated radiosensitization via augmentation of the Fas pathway in prostate cancer cells. Prostate 2003, 1, 14-23. (Pubitemid 37070145)
32. Grimstad, I. A. Growth and metastasis of hypermotile, hyperinvasive cancer cells selected in vitro by rapid locomotion under various conditions. Clin. Exp. Metast. 1988, 6, 257-69.
33. Hegedus, B.; Czirok, A.; Fazekas, I.; Babel, T.; Madarasz, E.; Vicsek, T. Locomotion and proliferation of glioblastoma cells in vitro: statistical evaluation of video microscopic observations. J. Neurosurg. 2000, 92, 428-43.
34. Gunnersen, J. M.; Spirkoska, V.; Smith, P. E.; Danks, R. A.; Tan, S. S. Growth and migration markers of rat C6 glioma cells identified by serial analysis of gene expression. Glia 2000, 32, 146-54.
35. Stierum, R.; Gaspari, M.; Dommels, Y.; Ouatas, T.; Pluk, H.; Jespersen, S.; Vogels, J.; Verhoeckx, K.; Groten, J.; Van Ommen, B. Proteome analysis reveals novel proteins associated with proliferation and differentiation of the colorectal cancer cell line Caco- 2. Biochim. Biophys. Acta 2003, 1650, 73-91. (Pubitemid 38234572)
36. Unwin, R. D.; Craven, R. A.; Harnden, P.; Hanrahan, S.; Totty, N.; Knowles, M.; Eardley, I.; Selby, P. J.; Banks, R. E. Proteomic changes in renal cancer and co-ordinate demonstration of both the glycolytic and mitochondrial aspects of the Warburg effect. Proteomics 2003, 3, 1620-32. (Pubitemid 37048086)
37. Jaattela, M.; Wissing, D. Heat shock proteins protects cells from monocyte cytotoxicity: possible mechanism of self-protection. J. Exp. Med. 1993, 177, 231-36. (Pubitemid 23008106)
38. Nylandsted, J.; Rohde, M.; Brand, K.; Bastholm, L.; Elling, F.; Jaattela, M. Selective depletion of heat shock protein 70 (Hsp70) activates a tumor-specific death program that is independent of caspases and bypasses Bcl-2. Proc. Natl. Acad. Sci. U.S.A. 2000, 97 (14), 7871-876. (Pubitemid 30460740)
39. Burkart, V.; Liu, H.; Bellmann, K.; Wissing, D.; Jaattela, M.; Cavallo, M. G.; Pozzilli, P.; Briviba, K.; Kolb, H. Natural resistance of human beta cells toward nitric oxide is mediated by heat shock protein 70. J. Biol. Chem. 2000, 275, 19521-528. (Pubitemid 30441544)
40. Beere, H. M.; Green, D. R. Stress management - heat shock protein- 70 and the regulation of apoptosis. Trends Cell Biol. 2001, 11, 6-10. (Pubitemid 32056181)
41. Volloch, V. Z.; Sherman, M. Y. Oncogenic potential of Hsp72. Oncogene 1999, 18, 3648-651. (Pubitemid 29322390)
42. Jolly, C.; Morimoto, R. I. J. Role of the heat shock response and molecular chaperones in oncogenesis and cell death. Natl. Cancer Inst. 2000, 92, 1564-572.
43. Rahbar, A. M.; Fenselau, C. Unbiased examination of changes in plasma membrane proteins in drug resistant cancer cells. J. Proteome Res. 2005, 4, 2148-153. (Pubitemid 41814282)
44. Mohr, S.; Keith, G.; Galateau-Salle, F.; Icard, P.; Rihn, B. H. Cell protection, resistance and invasiveness of two malignant mesotheliomas as assessed by 10K-microarray. Biochim. Biophys. Acta 2004, 1688, 43-60. (Pubitemid 38366304)
45. Wang, J.; Wakeman, T. P.; Lathia, J. D.; Hjelmeland, A. B.; Wang, X. F.; White, R. R.; Rich, J. N.; Sullenger, B. A. Notch promotes radioresistance of glioma stem cells. Stem Cells 2010, 28, 17-28.
46. Auger, N.; Thillet, J.; Wanherdrick, K.; Idbaih, A.; Legrier, M. E.; Dutrillaux, B.; Sanson, M.; Poupon, M. F. Genetic alterations associated with acquired Temozolomide resistance in SNB-19, a human glioma cell line. Mol. Cancer Ther. 2006, 5, 2182-92. (Pubitemid 44530454)
47. Leung, T. K.; Hall, C.; Rajendran, M.; Spurr, N. K.; Lim, L. 1992. The human heat-shock genes HSPA6 and HSPA7 are both expressed and localize to chromosome 1. Genomics 1992, 12, 74-79.
48. Staflin, K.; Zuchner, T.; Honeth, G.; Darabi, A.; Lundberg, C. Identification of proteins involved in neural progenitor cell targeting of gliomas. BMC Cancer 2009, 9, 206.
49. Jagadeeswaran, R.; Surawska, H.; Krishnaswamy, S.; Janamanchi, V.; Mackinnon, A. C.; Seiwert, T. Y.; Loganathan, S.; Kanteti, R.; Reichman, T.; Nallasura, V.; Schwartz, S.; Faoro, L.; Wang, Y. C.; Girard, L.; Tretiakova, M. S.; Ahmed, S.; Zumba, O.; Soulii, L.; Bindokas, V. P.; Szeto, L. L.; Gordon, G. J.; Bueno, R.; Sugarbaker, D.; Lingen, M. W.; Sattler, M.; Krausz, T.; Vigneswaran, W.; Natarajan, V.; Minna, J.; Vokes, E. E.; Ferguson, M. K.; Husain, A. N.; Salgia, R. Paxillin is a target for somatic mutations in lung cancer: implications for cell growth and invasion. Cancer Res. 2008, 68, 132-42. (Pubitemid 351380114)
50. Han, W.; Han, M. R.; Kang, J. J.; Bae, J. Y.; Lee, J. H.; Bae, Y. J.; Lee, J. E.; Shin, H. J.; Hwang, K. T.; Hwang, S. E.; Kim, S. W.; Noh, D. Y. Genomic alterations identified by array comparative genomic hybridization as prognostic markers in tamoxifen-treated estrogen receptor-positive breast cancer. BMC Cancer 2006, 6, 92.